Vimian Group AB (publ) (VIMGF)
OTCMKTS
· Delayed Price · Currency is USD
3.500
-0.385 (-9.91%)
At close: Dec 30, 2024
Vimian Group AB Market Cap
Vimian Group AB has a market cap or net worth of $1.89 billion as of February 5, 2025. Its market cap has increased by 65.60% in one year.
Market Cap
1.89B
Enterprise Value
2.11B
Revenue
393.03M
Ranking
n/a
PE Ratio
6,615.53
Stock Price
$3.50
Market Cap Chart
Since June 18, 2021, Vimian Group AB's market cap has decreased from 3.65B to 1.89B, a decrease of -48.19%. That is a compound annual growth rate of -16.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2025 | 1.88B | -0.21% |
| Dec 30, 2024 | 1.89B | 40.53% |
| Dec 29, 2023 | 1.34B | 23.45% |
| Dec 30, 2022 | 1.09B | -68.17% |
| Dec 30, 2021 | 3.41B | -6.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 2.13B |
| SS Innovations International | 1.45B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 807.06M |
| Elite Pharmaceuticals | 534.18M |
| Glass House Brands | 431.40M |
| Northwest Biotherapeutics | 386.06M |
| BioStem Technologies | 292.28M |